Study on infantile hemangioma: risk and treatment decisions
Part of Cancer clinical trials.
This study looks at babies with a type of birthmark called infantile hemangioma (including those that barely grow or have stopped growing). Researchers want to understand the risks and decide on the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between birth and 24 months old.
- Your baby has a hemangioma (a raised red birthmark) or a flat one that hasn't grown much.
- This is your first visit to a specialist for this hemangioma.
- Your baby has not had any previous treatment for the hemangioma, like medicine, lasers, or surgery.
- You, as a parent or guardian, can understand and agree to the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to stop giving propranolol to infants whose hemangiomas have fully resolved. The goal is to see which approach works better and which is safer.
This study screens infants with infantile hemangiomas (common benign blood vessel growths) in the lower body area to check for LUMBAR syndrome, a rare condition affecting multiple body systems. Early detection may help guide your child's care and monitoring.
This trial tests different starting doses of oral propranolol to see which works best and is safest for treating infantile hemangiomas that have ulcers (sores). It may help your child heal faster.
This study compares three approaches—pulsed-dye laser, timolol (a medicated skin solution), or watch-and-wait—to see which works best to slow the growth of a hemangioma birthmark in young babies. It may help find a treatment that shrinks or controls the birthmark as early as possible.
This study is testing a treatment for people with aggressive spinal hemangiomas—blood vessel growths in the spine that cause pain, weakness, or other symptoms. You may benefit if your hemangioma is causing problems and has been confirmed by imaging tests.
This study looks at how to best treat people with untreated cerebral cavernous malformations (a cluster of abnormal blood vessels in the brain). It compares outcomes between those who have surgery and those who are monitored with regular check-ups, and will follow participants for a long time to see how they do.
Hear when a new Infantile Hemangioma (IH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.